Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Elicio Therapeutics (ELTX) Assets Average (2021 - 2026)

Elicio Therapeutics filings provide 3 years of Assets Average readings, the most recent being $29.1 million for Q4 2023.

  • On a quarterly basis, Assets Average fell 30.78% to $29.1 million in Q4 2023 year-over-year; TTM through Dec 2023 was $29.1 million, a 30.78% decrease, with the full-year FY2023 number at $24.9 million, down 58.21% from a year prior.
  • Assets Average hit $29.1 million in Q4 2023 for Elicio Therapeutics, down from $34.3 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $132.3 million in Q2 2021 to a low of $29.1 million in Q4 2023.
  • Median Assets Average over the past 3 years was $71.0 million (2022), compared with a mean of $71.2 million.
  • Biggest five-year swings in Assets Average: dropped 4.7% in 2022 and later plummeted 63.76% in 2023.
  • Elicio Therapeutics' Assets Average stood at $103.2 million in 2021, then plummeted by 59.32% to $42.0 million in 2022, then tumbled by 30.78% to $29.1 million in 2023.
  • The last three reported values for Assets Average were $29.1 million (Q4 2023), $34.3 million (Q3 2023), and $39.7 million (Q2 2023) per Business Quant data.